Category: Product correction · Supplier: GlaxoSmithKline (GSK) Australia Pty Ltd
Recall date: 15 April 2026
GlaxoSmithKline (GSK) Australia Pty Ltd is issuing a product correction for certain batches of their Flixotide and Pavtide Accuhalers as a small number of Accuhalers may not automatically reload the next dose.
If the dose is not manually reset, this may lead to a short-term flare-up of asthma symptoms.
In the unlikely event you have an impacted device (where the lever is in the incorrect starting position) do not stop using your Accuhaler. You can manually reset the starting position by pushing the lever down towards the mouthpiece. Following this, push the lever up, away from the mouthpiece to 'load' the dose (as per normal instructions). This will cause the dose counter to change, indicating the Accuhaler has been reset correctly. If this problem occurs, you will need to reset the lever for each dose. After manually resetting the lever, a full dose will be delivered as normal. You should verify the dose counter advances. If this does not occur, the dose has not been delivered. If you have an Accuhaler from any of the batches listed above and are having any difficulties administering a dose, please contact your doctor or pharmacist for support.
Please contact GSK on 1800 033 109 for further information.
Explore more medicine recalls or run a broader search across all sources.